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Abstract
Djibouti is an East African country with a high tuberculosis
incidence. This study was conducted over a 2-month period in
Djibouti, during which 62 consecutive patients with pulmonary
tuberculosis (TB) were included. Genetic characterization of
Mycobacterium tuberculosis, using mycobacterial interspersed
repetitive-unit variable-number tandem-repeat typing and spoli-
gotyping, was performed. The genetic and phylogenetic analysis
revealed only three major families (Central Asian, East African
Indian and T). The high diversity and linkage disequilibrium
within each family suggest a long period of clonal evolution. A
Bayesian approach shows that the phylogenetic structure
observed in our sample of 62 isolates is very likely to be repre-
sentative of the phylogenetic structure of the M. tuberculosis
population in the total number of TB cases.
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Djibouti is an East African country with a total population of
over 819 000. In 2004, the estimated tuberculosis (TB) inci-
dence was 951 cases per 100 000 inhabitants, which is one
of the highest incidences in the world [1]. The objectives of
this study were to identify the Mycobacterium tuberculosis
families responsible for the TB cases, and to analyse their
genetic diversity and the structure of the M. tuberculosis
population in an area with this high TB incidence.
The study was conducted over a 2-month period at Paul
Faure Hospital in Djibouti City. During this period, 62 consec-
utive patients with symptomatic disease and sputum culture
positive for M. tuberculosis complex were included. Spoligotyp-
ing [2] and mycobacterial interspersed repetitive-unit variable-
number tandem-repeat (MIRU-VNTR) typing [3] was
performed with DNA from each isolate. To study the genetic
variability, a set of diversity indices, including genotypic
diversity and mean genetic diversity (H), was evaluated using
F-STAT version 2.9.3 [4]. The population structure was
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explored by analysis of linkage disequilibrium (LD) and calcula-
tion of Fst (index of genetic differentiation between samples)
using F-STAT version 2.9.3 [4]. Phylogenetic relationships
among the isolates were inferred from spoligotyping and
MIRU-VNTR data using UPGMA method and bootstrapping
procedures. Tree was built using PAUP 4.0 [5], and TreeDyn
software [6] was used for tree visualization and annotation.
The molecular M. tuberculosis complex identiﬁcation meth-
ods assigned all 62 isolates to the M. tuberculosis complex
and to M. tuberculosis sensu stricto. Twenty spoligotypes were
detected, of which 14 were already known in SpolDB4 [7],
and six were undescribed and unique. Three major types
were represented: the T family, the Delhi or Central Asian
(CAS) family and the East African Indian (EAI) family (Fig. 1).
The combined data allowed the generation of 57 distinct pat-
terns, with nine isolates grouped into four clusters (identical
genotypes) and 53 isolates with unique patterns (Fig. 1).
All trees built from the different datasets and using differ-
ent phylogenetic methods clearly distinguished three groups,
i.e. the EAI, T and CAS families, sustained by high bootstrap
values (>80). The genetic differentiation among these three
families was high and signiﬁcant (EAI vs. T, Fst = 0.65; EAI vs.
CAS, Fst = 0.73; T vs. CAS, Fst = 0.72; p <0.05).
An important polymorphism was revealed in this popula-
tion. The H index was not signiﬁcantly different in each group
and in the whole sample (p £0.05; 0.34). The genotypic diver-
sity index varied with the group (EAI and CAS = 100%; T =
83%; and 92% for the total sample). Moreover, the LD calcu-
lated on the basis of MIRU-VNTR data was highly signiﬁcant in
the entire population and in each group (p = 7.2 · 10)4),
FIG. 1. UPGMA tree based on combined data, spoligotypes and mycobacterial interspersed repetitive-unit variable-number tandem-repeats
(MIRU-VNTR) (24 loci) of the 62 samples under study (a Mycobacterium canettii stock was used as outgroup (a)). The relationships among
patterns were assessed using the UPGMA dendrogram. The spoligotypes listed correspond to the designation in the SpolDB4 database
((b)Mycobacterium tuberculosis complex (MTBC) lineages) and lineages were determined using SpolDB4 rules [7]. Unknown patterns match none
of the spoligotypes described in the SpolDB4 database. (c) MIRU-VNTR patterns for the 24 loci and for each isolate are displayed in each line.
The columns correspond to the MIRU-VNTR loci in the following order: MIRU02, VNTR0424, ETR C, MIRU04, MIRU40, MIRU10, MIRU16,
MIRU20, VNTR1955, MIRU23, MIRU24; MIRU26, MIRU27, MIRU31, MIRU39, ETR A, QUB-11b, VNTR2347, VNTR3171, QUB-26, VNTR2401,
VNTR3690, VNTR4156, and ETR B.
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suggesting, as already proposed for M. tuberculosis, clonal and
independent propagation within these phylogenetic lineages.
A major question when dealing with small sample sizes is
whether the conclusions reached from the analysis of the
sample can be generalized to the total population. In the con-
text of our study, whether the observed phylogenetic struc-
ture is an artefact of a small sample size or representative of
the total population is a major point to address. Using a
Bayesian framework [8,9], we estimated the probability distri-
butions of the proportions of total TB cases caused by each
of the three phylogenetic groups observed in Fig. 1 (marked
1, 2 and 3 in Fig. 2) and of total TB cases that were not
caused by any of the observed three groups in Fig. 1 (marked
0 in Fig. 2). As can be seen in Fig. 2, the posterior proportions
of sites not conforming to our observed phylogenetic struc-
ture are very low (mean 0.01474; 95% CI 0–0.19203). The
phylogenetic structure observed in our sample of 62 isolates
is thus very likely to be representative of the phylogenetic
structure in the total number of TB cases.
This study provides the ﬁrst analysis of M. tuberculosis fam-
ilies in Djibouti. As compared with SpolDB4, only three
major lineages, CAS, T and EAI, were identiﬁed, with no
genotype external to these three lineages (Fig. 1). The
M. tuberculosis molecular studies, in both developed and
developing countries, usually reveal few clusters associated
with a high variety of genotypes and families without strong
structuring [10–13]. This is all the more remarkable in that
Djibouti has long been considered to be a cosmopolitan
country with important immigration from Asian and African
countries. Moreover, other major families (LAM, Haarlem
and Beijing) circulate in neighbouring African countries
(Ethiopia, Kenya and Sudan) and Saudi Arabia [7,14,15].
The CAS and EAI families are prevalent in Central Asia
and East Asia, respectively [7]. Two hypotheses could explain
the presence of these families in Djibouti: (i) the large
Pakistani and South Asian communities in Djibouti may have
participated in the introduction of these families; or (ii) these
families could have emerged from Djibouti and migrated
through Asia, a hypothesis that is in agreement with the
suggestion that East Africa is the cradle of M. tuberculosis
complex species [16].
The LD observed in the entire sample but also in each
group and in each area is in agreement with the clonal struc-
ture proposed for M. tuberculosis. Thus, each lineage can be
considered to be a clone that evolves independently. In
countries where the TB incidence is low and therapeutic
management is effective, the spread of new genotypes is nor-
mally rapidly stopped, and these new strains ﬁnd no oppor-
tunity to propagate and evolve [10,17,18]. This would
explain the large variety of genotypes with only a few clus-
ters or lineages observed in these low-TB-incidence coun-
tries. In Djibouti, we noted only three lineages, and high
genetic diversity within each of them. A high incidence of TB
and the difﬁculties in treating the disease effectively result in
a relatively free circulation of genotypes, generating impor-
tant genetic diversity in each lineage.
The population structure observed in this study, three
individualized lineages with high genetic diversity, could
reﬂect evolution over a long period of time and a high
transmission level of circulating clones in Djibouti. In conclu-
sion, only three major M. tuberculosis families were identiﬁed
in our patients in Djibouti. The high diversity and the strong
LD within each family suggest a long period of clonal
evolution of the three lineages T, CAS and EAI in Djibouti.
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Abstract
Two identical isolates were recovered in pure culture from the
blood and urine of a patient suffering from severe septicaemia
associated with obstructive pyelonephritis secondary to litho-
tripsy. Preliminary phenotypic and genotypic characterizations
based on serological, biochemical and sequence analyses following
PCR ampliﬁcation of selected gene regions indicate that this
organism represents a potential new Francisella genomic species.
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